Gene Patents Draw U.S. High Court Review in Biotechnology Test

Gene Patents Draw U.S. High Court Review in Biotechnology Test

Chip Somodevilla/Getty Images

The U.S. Supreme Court justices today said they will hear a challenge to Myriad Genetics Inc.’s patents on genetic material used in tests for breast and ovarian cancer.